This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (19)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

ALFRED A. SMITH, MD, MS; JO ANN GAVITT, BA; META KARMIN, BA

Arch Ophthalmol. 1966;75(1):99-101.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Granular changes are seen in the lens and cornea of some patients given large doses of chlorpromazine.¹ The changes in the lens resemble the lenticular opacities induced in mice by the administration of narcotics of the morphine class² and by catecholamines.³ This report describes the formation in mice of lenticular opacities after chlorpromazine treatment. Attempts to block development of the cataract by sympatholytic compounds are discussed in relation to the effects of these compounds on opacities induced by catecholamines and narcotics.

Materials and Methods

Female Swiss-Webster mice, weighing 20 to 25 gm, were used throughout. All injections were given intraperitoneally in volumes between 0.1 and 0.2 ml except where indicated. Chlorpromazine hydrochloride (molecular weight, 355.3) was used as the commercially available preparation; epinephrine bitartrate (USP) and the levorphanol bitartrate were prepared before each use. The e inephrine solutions were administered in two stages, about 10% of the . . . [Full Text PDF of this Article]

Author Affiliations
New York

From the Department of Psychiatry and Neurology, New York University Medical Center, New York.

Footnotes
Submitted for publication June 30, 1965.

Reprint requests to Department of Psychiatry and Neurology, New York University Medical Center, New York, NY 10016 (Dr. Smith).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?